Answers are grounded in this paper and cite their sources.
DNMT3A mutations in patients with polycythemia vera were heterogeneous and not enriched in interferon alfa-treated patients. DNMT3A mutations had no detectable impact on the hematologic response, molecular response, or survival outcomes.
No takes yet. Share an insight, caveat, or question.
Abu‐Zeinah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: